These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 503235)

  • 1. Proposed structure of the anthramycin-DNA adduct.
    Hurley LH; Petrusek R
    Nature; 1979 Nov; 282(5738):529-31. PubMed ID: 503235
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of properties of the in vitro and cellular anthramycin-DNA adducts and characterization of the reaction of anthramycin with chromatin.
    Reynolds VL; Hurley LH
    Chem Biol Interact; 1982 Nov; 42(2):141-51. PubMed ID: 7151226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA.
    Kizu R; Draves PH; Hurley LH
    Biochemistry; 1993 Aug; 32(33):8712-22. PubMed ID: 8357813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug.
    Hurley LH; Allen CS; Feola JM; Lubawy WC
    Cancer Res; 1979 Aug; 39(8):3134-40. PubMed ID: 455297
    [No Abstract]   [Full Text] [Related]  

  • 5. Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell.
    Petrusek RL; Uhlenhopp EL; Duteau N; Hurley LH
    J Biol Chem; 1982 Jun; 257(11):6207-16. PubMed ID: 7076670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthramycin binding to deoxyribonucleic acid-mitomycin C complexes. Evidence for drug-induced deoxyribonucleic acid conformational change and cooperativity in mitomycin C binding.
    Kaplan DJ; Hurley LH
    Biochemistry; 1981 Dec; 20(26):7572-80. PubMed ID: 6798992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical conversion of anthramycin 11-methyl ether to didehydroanhydroanthramycin and its utilization in studies of the biosynthesis and mechanism of action of anthramycin.
    Malhotra RK; Ostrander JM; Hurley LH; McInnes AG; Smith DG; Walter JA; Wright JL
    J Nat Prod; 1981; 44(1):38-44. PubMed ID: 7217948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of binding of pyrrolo(1,4)benzodiazepine antitumour agents to deoxyribonucleic acid--anthramycin and tomaymycin.
    Lown JW; Joshua AV
    Biochem Pharmacol; 1979 Jul; 28(13):2017-26. PubMed ID: 224883
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition of the DNA helix stabilizing anthramycin-N2 guanine adduct by UVRABC nuclease.
    Walter RB; Pierce J; Case R; Tang MS
    J Mol Biol; 1988 Oct; 203(4):939-47. PubMed ID: 3210245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthramycin inhibition of restriction endonuclease cleavage and its use as a reversible blocking agent in DNA constructions.
    Sumner W; Bennett GN
    Nucleic Acids Res; 1981 May; 9(9):2105-19. PubMed ID: 6272225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the anthramycin-d(ATGCAT)2 adduct from one- and two-dimensional proton NMR experiments in solution.
    Graves DE; Stone MP; Krugh TR
    Biochemistry; 1985 Dec; 24(26):7573-81. PubMed ID: 4092025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical investigation of the sequence specificity in the binding of the antitumor drug anthramycin to DNA.
    Zakrzewska K; Pullman B
    J Biomol Struct Dyn; 1986 Aug; 4(1):127-36. PubMed ID: 3271432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sequence preference of tomaymycin- and anthramycin-DNA bonding by exonuclease III and lambda exonuclease digestion and UvrABC nuclease incision analysis.
    Pierce JR; Nazimiec M; Tang MS
    Biochemistry; 1993 Jul; 32(28):7069-78. PubMed ID: 8343501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a covalent DNA-drug adduct: anthramycin bound to C-C-A-A-C-G-T-T-G-G and a molecular explanation of specificity.
    Kopka ML; Goodsell DS; Baikalov I; Grzeskowiak K; Cascio D; Dickerson RE
    Biochemistry; 1994 Nov; 33(46):13593-610. PubMed ID: 7947769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reaction of anthramycin with DNA. Proton and carbon nuclear magnetic resonance studies on the structure of the anthramycin-DNA adduct.
    Graves DE; Pattaroni C; Krishnan BS; Ostrander JM; Hurley LH; Krugh TR
    J Biol Chem; 1984 Jul; 259(13):8202-9. PubMed ID: 6736032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs.
    Hertzberg RP; Hecht SM; Reynolds VL; Molineux IJ; Hurley LH
    Biochemistry; 1986 Mar; 25(6):1249-58. PubMed ID: 3008824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All atom molecular mechanics simulations on covalent complexes of anthramycin and neothramycin with deoxydecanucleotides.
    Rao SN; Remers WA
    J Med Chem; 1990 Jun; 33(6):1701-7. PubMed ID: 2342065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanics simulations on covalent complexes between anthramycin and B DNA.
    Rao SN; Singh UC; Kollman PA
    J Med Chem; 1986 Dec; 29(12):2484-92. PubMed ID: 3783608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional NMR studies on the anthramycin-d(ATGCAT)2 adduct.
    Krugh TR; Graves DE; Stone MP
    Biochemistry; 1989 Dec; 28(26):9988-94. PubMed ID: 2620069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B.
    Petrusek RL; Anderson GL; Garner TF; Fannin QL; Kaplan DJ; Zimmer SG; Hurley LH
    Biochemistry; 1981 Mar; 20(5):1111-9. PubMed ID: 6261786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.